Discovery and mechanism of negative allosteric modulation of the α7 nicotinic acetylcholine receptor by nanobodies
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2514734123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Nathalie Barilone und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Department, Signaling and Receptors Dynamics Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3571, Paris 75015, France. Hauptthemen laut MEDLINE: alpha7 Nicotinic Acetylcholine Receptor, Single-Domain Antibodies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EC | European Research Council (ERC), Agence Nationale de la Recherche (ANR).
Abstract (Originalsprache)
α7 nicotinic receptors are neurotransmitter-gated ion channels involved in neurological and inflammatory diseases. Ligands acting on its neurotransmitter binding site and on the channel domain of α7 have been extensively developed, yielding a wide range of orthosteric effectors and allosteric positive modulators. Here, we present the functional and structural characterization of two camelid antibody fragments, or nanobodies, F1 and E6, that inhibit α7 activity by acting as negative allosteric modulators, an underrepresented class of ligands. Cryo-EM structures of the nanobodies in complex with α7 show that both nanobodies form a pentameric bundle at the apex of the receptor, each nanobody interacting through a conserved set of residues at α7 subunit interfaces. Electrophysiological experiments suggest that E6 inhibits the activity of α7 by stabilizing its resting conformation, and that internanobodies interactions are key to its activity. Those two nanobodies expand the toolbox for human α7 modulation, opening new possibilities for its pharmacological control with far reaching potentialities in clinics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroscience Department, Signaling and Receptors Dynamics Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3571, Paris 75015, France.
- Lanzhou Institute of Biological Product Co., Lanzhou 730000, China.
- Center for Technological Resources and Research, Antibody Engineering platform, Institut Pasteur, Université Paris Cité, CNRS UMR 3528, Paris 75015, France.
ORCID-Profile: Nathalie Barilone, F Zahra Marouf, Pierre Lafaye, Gabriel Aymé, Marie S Prevost
Förderung
- EC | European Research Council (ERC)
- Agence Nationale de la Recherche (ANR)
Zitieren
APA
Barilone, N., Vangelatou, M., Marouf, F. Z., Dejean de la Bâtie, G., Li, Q., Lafaye, P., Aymé, G., Corringer, P. J., & Prevost, M. S. (2026). Discovery and mechanism of negative allosteric modulation of the α7 nicotinic acetylcholine receptor by nanobodies. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2514734123
Vancouver
Barilone N, Vangelatou M, Marouf FZ, Dejean de la Bâtie G, Li Q, Lafaye P, et al. Discovery and mechanism of negative allosteric modulation of the α7 nicotinic acetylcholine receptor by nanobodies. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2514734123
BibTeX
@article{Barilone2026,
author = {Barilone, Nathalie and Vangelatou, Maria and Marouf, F Zahra and Dejean de la Bâtie, Gabrielle and Li, Qimeng and Lafaye, Pierre and Aymé, Gabriel and Corringer, Pierre-Jean and Prevost, Marie S},
title = {Discovery and mechanism of negative allosteric modulation of the α7 nicotinic acetylcholine receptor by nanobodies},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2514734123}
}
EUVIMED